Market Tracker

10/31 7:05pm ET

Synageva BioPharma Corp (NASDAQ:GEVA)

75.74
Data as of Oct 31
 -4.32 / -5.40%
Today’s Change
44.54
Today|||52-Week Range
119.42
+17.03%
Year-to-Date
No recent news for Synageva BioPharma Corp.

Today’s Trading

Previous close80.06
Today’s open81.00
Day’s range75.41 - 86.26
Volume355,280
Average volume (3 months)254,599
Market cap$2.7B
Dividend yield--
Data as of 10/31/2014

Growth & Valuation

Earnings growth (last year)-78.95%
Earnings growth (this year)-81.14%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-10.57%
P/E ratio--
Price/Sales135.92
Price/Book5.73

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp-0.57-2.49%
OPHTOphthotech Corp-0.09-0.22%
KITEKite Pharma Inc+1.25+3.50%
NVAXNovavax Inc-0.03-0.53%
Data as of 10/31/2014

Financials

Next reporting dateMarch 9, 2015
EPS forecast (this quarter)-$1.82
Annual revenue (last year)$13.4M
Annual profit (last year)-$95.5M
Net profit margin-713.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts

Chart unavailable